Shanghai, China

Jason Guohua Chen




Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jason Guohua Chen: Innovator in Imidazole-Based Compounds

Introduction

Jason Guohua Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of chemistry, particularly in the development of methods for preparing imidazole-based bicyclic compounds. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this specialized area.

Latest Patents

Jason holds a patent for "Methods of preparing imidazole-based bicyclic compounds." This patent outlines the methods for preparing compounds of formula I, which are crucial for various applications in chemical synthesis. His work in this domain has resulted in 1 patent, reflecting his commitment to advancing scientific knowledge and practical applications.

Career Highlights

Currently, Jason is employed at Lexicon Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical research and development. His role at the company allows him to collaborate with other talented professionals in the field, contributing to innovative solutions in drug discovery and development.

Collaborations

Throughout his career, Jason has worked alongside notable colleagues such as Weifeng Hu and Renmao Liu. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.

Conclusion

In summary, Jason Guohua Chen is a dedicated inventor whose work in imidazole-based compounds has made a notable impact in the field of chemistry. His contributions through patents and collaborations highlight his role as a key player in advancing scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…